期刊文献+

肝病患者血生化及凝血酶原时间检测的临床意义 被引量:4

The significance of the biochemistry and prothrombin time in patients with liver disease
原文传递
导出
摘要 目的:探讨总胆汁酸(TBA)、胆碱酯酶(CHE)、白蛋白(ALB)、前白蛋白(PAB)、谷丙转氨酶(ALT)以及凝血酶原时间(PT)对各种肝病患者的诊断价值。方法:检测648例各类肝病患者及134例正常人的TBA、CHE、ALB、PAB、ALT和PT。结果:TBA、CHE、PAB、ALT和PT在急性黄疸肝炎、慢性肝炎、肝炎后肝硬化、肝癌组和正常对照组均有明显区别,而ALB在急性黄疸性肝炎患者和正常对照组无明显差别;急性黄疸性肝炎中ALT灵敏度最高,ALB灵敏度最低,肝炎后肝硬化中PAB灵敏度最高,慢性重度肝炎中,除ALT外,其余五项指标灵敏度均为100%;随着肝炎后肝硬化和重型肝炎的好转,TBA、ALT、PT会有一定程度的降低,CHE、ALB、PAB会有一定程度的升高,其中TBA、CHE、PAB、ALT、PT的改变均有统计学意义。结论:联合检测TBA、CHE、ALB、PAB、ALT及PT对肝病患者的临床诊断、病情判断及预后有一定参考价值。 Objective:To discuss the diagnostic value of the examination of serum TBA,CHE,ALB,PAB,ALT,PT in the patients suffering from liver diseases.Methods: TBA,CHE,ALB,PAB,ALT and PT were examined with auto biochemical analyzer and STAGO active hemagglutination apparatus in 648 hepatitis cases and 134 healthy cases.Results: The mean values of TBA,CHE,PAB,ALT,PT in acute hepatitis patients,chronic hepatitis patients,liver cirrhosis patients and liver cancer were significantly higher than those of healthy cases.Sensitivity of ALT is highest and sensitivity of ALB is lowest in acute icterohepatitis.Sensitivity of PAB is highest in posthepatitic cirnhosis.The sensitivity of five index were 100% except ALT in chronic heavy hepatitis.Along with posthepatitic cirrhosis and heavy hepatitis improving,the value of TBA,ALT and PT were lower and the CHE,ALB and PAB were heighten.Conclusion: It is valuable to associate measure TBA,CHE,ALB,PAB,ALT and PT in the hepatopath clinical diagnosis,patient′s condition judgement and prognosis.
出处 《中国卫生检验杂志》 CAS 2011年第4期945-947,共3页 Chinese Journal of Health Laboratory Technology
关键词 肝病 前白蛋白 总胆汁酸 胆碱酯酶 凝血酶原时间 Liver diseases Prealbumin(PAB) Total bile acid(TBA) Cholinesterase(CHE) PT
  • 相关文献

参考文献11

二级参考文献34

  • 1张利年,王鸿利,支立民,黄霞萍,邵慧珍.肝硬化患者凝血功能的研究[J].上海第二医科大学学报,1993,13(3):219-222. 被引量:8
  • 2Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973,60:646-649.
  • 3Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001,33: 464-470.
  • 4Rodriguez-Inigo E, Bartolome J, Quiroga JA, et al. Expression of factor VII in the liver of patients with liver disease: correlations with the disease severity and impairment in the hemostasis. Blood Coagul Fibrinolysis, 2001, 12: 193-199.
  • 5Fernandez E, Rodrigo L, Riestra S, et al. Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J Clin Gastroenterol,2000,30 : 181-186.
  • 6Kobayashi F, Ikeda T, Marumo F, et al. Adenosine deaminase isoenzymes in liver disease. Am J Gastroenterol, 1993,88:266-271.
  • 7Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end- stage liver disease. Hepatology, 2001,33: 464-470.
  • 8Ishikawa M, Yogita S, Miyake H, et al. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.Hepatogastroenterology, 2002, 49: 1625-1631.
  • 9Schepis F, Camma C, Niceforo D, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology, 2001, 33: 333-338.
  • 10Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut, 2003,52: 134-139.

共引文献14156

同被引文献42

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部